STUB1 and cancer: The patients enrolled in this study previously exposed to any type of cancer therapy (cytotoxic, radiation, immunological or targeted therapies) had higher odds of harboring CHIP (odds ratio (OR) = 1.3, p = 1 × 10−6), similar to current and/or former smokers (OR = 1.1, p = 5 × 10−3) [55].